Terms: = Breast cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
418 results:
1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
2. cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs.
Gholamzad A; Khakpour N; Khosroshahi EM; Asadi S; Koohpar ZK; Matinahmadi A; Jebali A; Rashidi M; Hashemi M; Sadi FH; Gholamzad M
Pathol Res Pract; 2024 Apr; 256():155227. PubMed ID: 38490099
[TBL] [Abstract] [Full Text] [Related]
3. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.
Khan AJ; Man S; Abbas M; Liu S; Zhang F
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130577. PubMed ID: 38301858
[TBL] [Abstract] [Full Text] [Related]
4. Influence of copper(I) nicotinate complex on the notch1 signaling pathway in triple negative breast cancer cell lines.
Abdel-Mohsen MA; Badawy AM; Abu-Youssef MA; Yehia MA; Abou Shamaa LD; Mohamed SA
Sci Rep; 2024 Jan; 14(1):2522. PubMed ID: 38291201
[TBL] [Abstract] [Full Text] [Related]
5. Central Role of β-1,4-GalT-V in cancer Signaling, Inflammation, and Other Disease-Centric Pathways.
Chatterjee S; Yuan R; Thapa S; Talwar R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203654
[TBL] [Abstract] [Full Text] [Related]
6. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells.
Shuaib M; Kumar S
Pathol Res Pract; 2024 Jan; 253():155017. PubMed ID: 38101160
[TBL] [Abstract] [Full Text] [Related]
7. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting notch1-Jagged1/NF-κB(p65) signaling.
Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
[TBL] [Abstract] [Full Text] [Related]
8. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract] [Full Text] [Related]
9. Comparative analysis of mutational patterns in triple negative breast cancer before and after neoadjuvant chemotherapy in patients with residual disease.
Singh A; Georgy JT; Dhananjayan S; Sigamani E; John AO; Joel A; Chandramohan J; Abarna R; Rebekah G; Backianathan S; Abraham DT; Paul MJ; Chacko RT; Manipadam MT; Pai R
Gene; 2024 Feb; 895():147980. PubMed ID: 37951371
[TBL] [Abstract] [Full Text] [Related]
10. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
Hossain F; Ucar DA; Monticone G; Ran Y; Majumder S; Larter K; Luu H; Wyczechowska D; Heidari S; Xu K; Shanthalingam S; Matossian M; Xi Y; Burow M; Collins-Burow B; Del Valle L; Hicks C; Zabaleta J; Golde T; Osborne B; Miele L
Front Immunol; 2023; 14():1244159. PubMed ID: 37901240
[TBL] [Abstract] [Full Text] [Related]
11.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic Profiles of Triple-Negative breast cancers of African American and White Females.
Ensenyat-Mendez M; Solivellas-Pieras M; Llinàs-Arias P; Íñiguez-Muñoz S; Baker JL; Marzese DM; DiNome ML
JAMA Netw Open; 2023 Oct; 6(10):e2335821. PubMed ID: 37796506
[TBL] [Abstract] [Full Text] [Related]
13. Matrine exerts an anti-tumor effect via regulating hn1 in triple breast cancer both in vitro and in vivo.
Guo Q; Yu Y; Tang W; Zhou S; Lv X
Chem Biol Drug Des; 2023 Dec; 102(6):1469-1477. PubMed ID: 37674344
[TBL] [Abstract] [Full Text] [Related]
14. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
15. Estrogen-Related Receptor Alpha (ERRα) Promotes cancer Stem Cell-Like Characteristics in breast cancer.
Muduli K; Prusty M; Pradhan J; Samal AP; Sahu B; Roy DS; Reddy KS; Elangovan S
Stem Cell Rev Rep; 2023 Nov; 19(8):2807-2819. PubMed ID: 37584854
[TBL] [Abstract] [Full Text] [Related]
16. Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer.
Xiao G; Cheng F; Yuan J; Lu W; Wang P; Fan H
Oncol Res; 2022; 30(1):35-51. PubMed ID: 37304008
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.
Sohel M; Aktar S; Biswas P; Amin MA; Hossain MA; Ahmed N; Mim MIH; Islam F; Mamun AA
Cancer Med; 2023 Jul; 12(13):14556-14583. PubMed ID: 37132286
[TBL] [Abstract] [Full Text] [Related]
18. Cooperative NF-κB and notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer.
Duran CL; Karagiannis GS; Chen X; Sharma VP; Entenberg D; Condeelis JS; Oktay MH
Breast Cancer Res; 2023 Apr; 25(1):37. PubMed ID: 37024946
[TBL] [Abstract] [Full Text] [Related]
19. Clinical significance of Notch receptors in triple negative breast cancer.
Shah H; Mistry M; Patel N; Vora H
Breast Dis; 2023; 42(1):85-100. PubMed ID: 36970890
[TBL] [Abstract] [Full Text] [Related]
20. Expression analysis of novel long non-coding RNAs for invasive ductal and invasive lobular breast carcinoma cases.
Aktan Ç; Küçükaslan AŞ; Türk BA; Yildirim I
Pathol Res Pract; 2023 Apr; 244():154391. PubMed ID: 36868097
[TBL] [Abstract] [Full Text] [Related]
[Next]
